Immunotherapy MCQs with Answers

Immunotherapy MCQs are very important test and often asked by various testing services and competitive exams around the world. Here you will find all the Important Immunotherapy MCQs for Preparation.

The student can clear their concepts for Immunotherapy online quiz by attempting it. Doing MCQs based Immunotherapy will help you to check your understanding and identify areas of improvement.

Immunotherapy Online MCQs with Answers

Immunotherapy is a type of treatment that:
a) Uses drugs to kill cancer cells
b) Boosts the body’s immune system to fight diseases
c) Involves surgical removal of tumors
d) Relies on radiation therapy to target cancer cells

Answer
b) Boosts the body’s immune system to fight diseases

Which of the following is an example of a type of immunotherapy used in cancer treatment?
a) Antibiotics
b) Chemotherapy
c) Vaccines
d) Painkillers

Answer
c) Vaccines

The primary goal of immunotherapy in cancer treatment is to:
a) Eliminate all cancer cells from the body
b) Prevent the spread of cancer to other organs
c) Boost the immune system’s ability to recognize and attack cancer cells
d) Reduce the side effects of chemotherapy and radiation therapy

Answer
c) Boost the immune system’s ability to recognize and attack cancer cells

Which of the following immune cells is targeted in immunotherapy for cancer treatment?
a) T cells
b) B cells
c) Natural killer cells
d) Macrophages

Answer
a) T cells

CAR-T cell therapy is a type of immunotherapy that involves:
a) Injection of cancer-killing viruses into the body
b) Administration of antibodies to target cancer cells
c) Modification of a patient’s own T cells to recognize and attack cancer cells
d) Transplantation of bone marrow to boost the immune system

Answer
c) Modification of a patient’s own T cells to recognize and attack cancer cells

Checkpoint inhibitors are a type of immunotherapy that:
a) Enhance the activation of immune cells
b) Block the function of proteins that inhibit the immune response
c) Boost the production of antibodies by B cells
d) Stimulate the release of pro-inflammatory cytokines

Answer
b) Block the function of proteins that inhibit the immune response

Which of the following is an example of a checkpoint inhibitor used in immunotherapy?
a) Rituximab
b) Trastuzumab
c) Pembrolizumab
d) Bevacizumab

Answer
c) Pembrolizumab

Adoptive cell transfer is an immunotherapy approach that involves:
a) Administration of small molecules that enhance immune response
b) Injection of cancer-killing viruses into the body
c) Transfer of immune cells from a donor to a patient
d) Induction of immune tolerance to prevent autoimmune reactions

Answer
c) Transfer of immune cells from a donor to a patient

Which of the following is an example of a cytokine used in immunotherapy?
a) Interferon
b) Rituximab
c) Trastuzumab
d) Pembrolizumab

Answer
a) Interferon

The purpose of cancer vaccines in immunotherapy is to:
a) Prevent the occurrence of cancer in healthy individuals
b) Boost the immune system’s ability to recognize and attack cancer cells
c) Replace damaged genes in cancer cells
d) Reduce the side effects of chemotherapy and radiation therapy

Answer
b) Boost the immune system’s ability to recognize and attack cancer cells

Which of the following is a potential side effect of immunotherapy?
a) Hair loss
b) Fatigue
c) Nausea and vomiting
d) Autoimmune reactions

Answer
d) Autoimmune reactions

Which of the following is a potential challenge in the development of immunotherapy treatments?
a) Limited availability of cancer vaccines
b) High cost of immunotherapy drugs
c) Lack of patient compliance
d) Inadequate funding for immunotherapy research

Answer
b) High cost of immunotherapy drugs

The use of immunotherapy has revolutionized the treatment of which type of cancer?
a) Breast cancer
b) Lung cancer
c) Colorectal cancer
d) Prostate cancer

Answer
b) Lung cancer

Which of the following is an example of a monoclonal antibody used in immunotherapy?
a) Interferon-alpha
b) Rituximab
c) Aldesleukin
d) Ipilimumab

Answer
b) Rituximab

Which of the following is a potential advantage of immunotherapy over traditional cancer treatments?
a) Lower cost
b) Less invasive procedures
c) Faster treatment outcomes
d) Higher success rates

Answer
d) Higher success rates

Which of the following is a potential limitation of immunotherapy?
a) Risk of allergic reactions
b) Limited availability of immunotherapy drugs
c) Inability to target specific cancer cells
d) Lack of patient compliance

Answer
b) Limited availability of immunotherapy drugs

The immune system uses which of the following mechanisms to identify and eliminate cancer cells?
a) Production of antibodies
b) Activation of T cells
c) Release of pro-inflammatory cytokines
d) Phagocytosis by macrophages

Answer
b) Activation of T cells

Which of the following is a type of immunotherapy used in the treatment of allergies?
a) Allergen-specific immunotherapy
b) CAR-T cell therapy
c) Checkpoint inhibitors
d) Cytokine therapy

Answer
a) Allergen-specific immunotherapy

Which of the following is an example of a targeted therapy used in combination with immunotherapy?
a) Chemotherapy
b) Radiation therapy
c) Surgery
d) Tyrosine kinase inhibitors

Answer
d) Tyrosine kinase inhibitors

Which of the following is an example of a cancer type that has shown positive responses to immunotherapy?
a) Pancreatic cancer
b) Leukemia
c) Ovarian cancer
d) Melanoma

Answer
d) Melanoma

Which of the following immune cells plays a central role in coordinating the immune response in immunotherapy?
a) T cells
b) B cells
c) Natural killer cells
d) Dendritic cells

Answer
d) Dendritic cells

Which of the following is a potential side effect of checkpoint inhibitors in immunotherapy?
a) Hair loss
b) Nausea and vomiting
c) Fatigue
d) Immune-related adverse events

Answer
d) Immune-related adverse events

What is the primary mechanism of action of CAR-T cell therapy?
a) Activation of the immune system
b) Inhibition of tumor growth
c) Destruction of cancer cells by modified T cells
d) Stimulation of antibody production

Answer
c) Destruction of cancer cells by modified T cells

Which of the following is a potential challenge in the personalized use of immunotherapy?
a) Limited availability of targeted therapies
b) Lack of understanding of the immune system
c) Inadequate funding for immunotherapy research
d) Difficulty in identifying suitable targets for individual patients

Answer
d) Difficulty in identifying suitable targets for individual patients

Which of the following is an example of a cytokine used in immunotherapy for the treatment of melanoma?
a) Interleukin-2
b) Trastuzumab
c) Bevacizumab
d) Pembrolizumab

Answer
a) Interleukin-2

Which of the following is a potential challenge in the development of cancer vaccines for immunotherapy?
a) Lack of awareness about cancer vaccines among patients
b) Difficulty in identifying suitable antigens for each cancer type
c) High cost of cancer vaccine production
d) Limited availability of clinical trials for cancer vaccines

Answer
b) Difficulty in identifying suitable antigens for each cancer type

Which of the following is an example of an immune checkpoint targeted by immunotherapy?
a) PD-1
b) HER2
c) EGFR
d) KRAS

Answer
a) PD-1

Which of the following is a potential limitation of CAR-T cell therapy?
a) High cost of treatment
b) Limited availability of CAR-T cell therapies
c) Risk of graft-versus-host disease
d) Inability to target specific cancer cells

Answer
b) Limited availability of CAR-T cell therapies

Which of the following is a potential side effect of cytokine therapy in immunotherapy?
a) Allergic reactions
b) Nausea and vomiting
c) Fatigue
d) Flu-like symptoms

Answer
d) Flu-like symptoms

Which of the following is a potential advantage of immunotherapy in the treatment of cancer?
a) Immediate tumor shrinkage
b) Reduction in treatment duration
c) Potential for long-term remission
d) Lower cost compared to chemotherapy

Answer
c) Potential for long-term remission

Which of the following is a potential challenge in the administration of CAR-T cell therapy?
a) Limited availability of T cells for modification
b) Risk of cytokine release syndrome
c) Inability to target specific cancer cells
d) High cost of CAR-T cell production

Answer
b) Risk of cytokine release syndrome

Which of the following is a potential limitation of immunotherapy in cancer treatment?
a) Risk of allergic reactions
b) Inability to target specific cancer cells
c) Limited availability of immunotherapy drugs
d) Lack of patient compliance

Answer
b) Inability to target specific cancer cells

Which of the following is an example of an immune checkpoint targeted by immunotherapy?
a) VEGF
b) ALK
c) CTLA-4
d) BCR-ABL

Answer
c) CTLA-4

Which of the following is a potential challenge in the development of cancer vaccines for immunotherapy?
a) Limited availability of targeted therapies
b) Difficulty in identifying suitable antigens for each cancer type
c) Inadequate funding for cancer vaccine research
d) Lack of understanding of the immune system

Answer
b) Difficulty in identifying suitable antigens for each cancer type

Which of the following is an example of a targeted therapy used in combination with immunotherapy?
a) Chemotherapy
b) Radiation therapy
c) Surgery
d) Tyrosine kinase inhibitors

Answer
d) Tyrosine kinase inhibitors

Which of the following is a potential side effect of immunotherapy?
a) Hair loss
b) Fatigue
c) Nausea and vomiting
d) Autoimmune reactions

Answer
d) Autoimmune reactions

Which of the following is a potential challenge in the development of immunotherapy treatments?
a) Limited availability of cancer vaccines
b) High cost of immunotherapy drugs
c) Lack of patient compliance
d) Inadequate funding for immunotherapy research

Answer
b) High cost of immunotherapy drugs

The use of immunotherapy has revolutionized the treatment of which type of cancer?
a) Breast cancer
b) Lung cancer
c) Colorectal cancer
d) Prostate cancer

Answer
b) Lung cancer

Which of the following is an example of a monoclonal antibody used in immunotherapy?
a) Interferon-alpha
b) Rituximab
c) Aldesleukin
d) Ipilimumab

Answer
b) Rituximab

Which of the following is a potential advantage of immunotherapy over traditional cancer treatments?
a) Lower cost
b) Less invasive procedures
c) Faster treatment outcomes
d) Higher success rates

Answer
d) Higher success rates

Which of the following is a potential limitation of immunotherapy?
a) Risk of allergic reactions
b) Limited availability of immunotherapy drugs
c) Inability to target specific cancer cells
d) Lack of patient compliance

Answer
b) Limited availability of immunotherapy drugs

The immune system uses which of the following mechanisms to identify and eliminate cancer cells?
a) Production of antibodies
b) Activation of T cells
c) Release of pro-inflammatory cytokines
d) Phagocytosis by macrophages

Answer
b) Activation of T cells

Which of the following is a type of immunotherapy used in the treatment of allergies?
a) Allergen-specific immunotherapy
b) CAR-T cell therapy
c) Checkpoint inhibitors
d) Cytokine therapy

Answer
a) Allergen-specific immunotherapy

Which of the following is an example of a targeted therapy used in combination with immunotherapy?
a) Chemotherapy
b) Radiation therapy
c) Surgery
d) Tyrosine kinase inhibitors

Answer
d) Tyrosine kinase inhibitors

Which of the following is an example of a cancer type that has shown positive responses to immunotherapy?
a) Pancreatic cancer
b) Leukemia
c) Ovarian cancer
d) Melanoma

Answer
d) Melanoma

Which of the following immune cells plays a central role in coordinating the immune response in immunotherapy?
a) T cells
b) B cells
c) Natural killer cells
d) Dendritic cells

Answer
d) Dendritic cells

Which of the following is a potential side effect of checkpoint inhibitors in immunotherapy?
a) Hair loss
b) Nausea and vomiting
c) Fatigue
d) Immune-related adverse events

Answer
d) Immune-related adverse events

What is the primary mechanism of action of CAR-T cell therapy?
a) Activation of the immune system
b) Inhibition of tumor growth
c) Destruction of cancer cells by modified T cells
d) Stimulation of antibody production

Answer
c) Destruction of cancer cells by modified T cells

Which of the following is a potential challenge in the personalized use of immunotherapy?
a) Limited availability of targeted therapies
b) Lack of understanding of the immune system
c) Inadequate funding for immunotherapy research
d) Difficulty in identifying suitable targets for individual patients

Answer
d) Difficulty in identifying suitable targets for individual patients

Which of the following is an example of a cytokine used in immunotherapy for the treatment of melanoma?
a) Interleukin-2
b) Trastuzumab
c) Bevacizumab
d) Pembrolizumab

Answer
a) Interleukin-2

Which of the following is a potential challenge in the development of cancer vaccines for immunotherapy?
a) Lack of awareness about cancer vaccines among patients
b) Difficulty in identifying suitable antigens for each cancer type
c) High cost of cancer vaccine production
d) Limited availability of clinical trials for cancer vaccines

Answer
b) Difficulty in identifying suitable antigens for each cancer type

Which of the following is an example of an immune checkpoint targeted by immunotherapy?
a) PD-1
b) HER2
c) EGFR
d) KRAS

Answer
a) PD-1

Which of the following is a potential limitation of CAR-T cell therapy?
a) High cost of treatment
b) Limited availability of CAR-T cell therapies
c) Risk of graft-versus-host disease
d) Inability to target specific cancer cells

Answer
b) Limited availability of CAR-T cell therapies

Which of the following is a potential side effect of cytokine therapy in immunotherapy?
a) Allergic reactions
b) Nausea and vomiting
c) Fatigue
d) Flu-like symptoms

Answer
d) Flu-like symptoms

Which of the following is a potential advantage of immunotherapy in the treatment of cancer?
a) Immediate tumor shrinkage
b) Reduction in treatment duration
c) Potential for long-term remission
d) Lower cost compared to chemotherapy

Answer
c) Potential for long-term remission

Which of the following is a potential challenge in the administration of CAR-T cell therapy?
a) Limited availability of T cells for modification
b) Risk of cytokine release syndrome
c) Inability to target specific cancer cells
d) High cost of CAR-T cell production

Answer
b) Risk of cytokine release syndrome

Which of the following is a potential limitation of immunotherapy in cancer treatment?
a) Risk of allergic reactions
b) Inability to target specific cancer cells
c) Limited availability of immunotherapy drugs
d) Lack of patient compliance

Answer
b) Inability to target specific cancer cells

Which of the following is an example of an immune checkpoint targeted by immunotherapy?
a) VEGF
b) ALK
c) CTLA-4
d) BCR-ABL

Answer
c) CTLA-4

Which of the following is a potential challenge in the development of cancer vaccines for immunotherapy?
a) Limited availability of targeted therapies
b) Difficulty in identifying suitable antigens for each cancer type
c) Inadequate funding for cancer vaccine research
d) Lack of understanding of the immune system

Answer
b) Difficulty in identifying suitable antigens for each cancer type

Which of the following is an example of a targeted therapy used in combination with immunotherapy?
a) Chemotherapy
b) Radiation therapy
c) Surgery
d) Tyrosine kinase inhibitors

Answer
d) Tyrosine kinase inhibitors

Which of the following is a potential side effect of immunotherapy?
a) Hair loss
b) Fatigue
c) Nausea and vomiting
d) Autoimmune reactions

Answer
d) Autoimmune reactions

Which of the following is a potential challenge in the development of immunotherapy treatments?
a) Limited availability of cancer vaccines
b) High cost of immunotherapy drugs
c) Lack of patient compliance
d) Inadequate funding for immunotherapy research

Answer
b) High cost of immunotherapy drugs

The use of immunotherapy has revolutionized the treatment of which type of cancer?
a) Breast cancer
b) Lung cancer
c) Colorectal cancer
d) Prostate cancer

Answer
b) Lung cancer

Which of the following is an example of a monoclonal antibody used in immunotherapy?
a) Interferon-alpha
b) Rituximab
c) Aldesleukin
d) Ipilimumab

Answer
b) Rituximab

Which of the following is a potential advantage of immunotherapy over traditional cancer treatments?
a) Lower cost
b) Less invasive procedures
c) Faster treatment outcomes
d) Higher success rates

Answer
d) Higher success rates

Which of the following is a potential limitation of immunotherapy?
a) Risk of allergic reactions
b) Limited availability of immunotherapy drugs
c) Inability to target specific cancer cells
d) Lack of patient compliance

Answer
b) Limited availability of immunotherapy drugs

The immune system uses which of the following mechanisms to identify and eliminate cancer cells?
a) Production of antibodies
b) Activation of T cells
c) Release of pro-inflammatory cytokines
d) Phagocytosis by macrophages

Answer
b) Activation of T cells

Which of the following is a type of immunotherapy used in the treatment of allergies?
a) Allergen-specific immunotherapy
b) CAR-T cell therapy
c) Checkpoint inhibitors
d) Cytokine therapy

Answer
a) Allergen-specific immunotherapy

Which of the following is an example of a targeted therapy used in combination with immunotherapy?
a) Chemotherapy
b) Radiation therapy
c) Surgery
d) Tyrosine kinase inhibitors

Answer
d) Tyrosine kinase inhibitors

Which of the following is an example of a cancer type that has shown positive responses to immunotherapy?
a) Pancreatic cancer
b) Leukemia
c) Ovarian cancer
d) Melanoma

Answer
d) Melanoma

 

Leave a Comment